These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 34159305)

  • 1. Novel vectors and approaches for gene therapy in liver diseases.
    Maestro S; Weber ND; Zabaleta N; Aldabe R; Gonzalez-Aseguinolaza G
    JHEP Rep; 2021 Aug; 3(4):100300. PubMed ID: 34159305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient
    Ginn SL; Amaya AK; Liao SHY; Zhu E; Cunningham SC; Lee M; Hallwirth CV; Logan GJ; Tay SS; Cesare AJ; Pickett HA; Grompe M; Dilworth K; Lisowski L; Alexander IE
    JHEP Rep; 2020 Feb; 2(1):100065. PubMed ID: 32039406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curative Ex Vivo Hepatocyte-Directed Gene Editing in a Mouse Model of Hereditary Tyrosinemia Type 1.
    VanLith C; Guthman R; Nicolas CT; Allen K; Du Z; Joo DJ; Nyberg SL; Lillegard JB; Hickey RD
    Hum Gene Ther; 2018 Nov; 29(11):1315-1326. PubMed ID: 29764210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precise Genome Modification via Sequence-Specific Nucleases-Mediated Gene Targeting for Crop Improvement.
    Sun Y; Li J; Xia L
    Front Plant Sci; 2016; 7():1928. PubMed ID: 28066481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice.
    Ohmori T; Nagao Y; Mizukami H; Sakata A; Muramatsu SI; Ozawa K; Tominaga SI; Hanazono Y; Nishimura S; Nureki O; Sakata Y
    Sci Rep; 2017 Jun; 7(1):4159. PubMed ID: 28646206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent developments in enhancing the efficiency of CRISPR/Cas9- mediated knock-in in animals].
    Li GL; Yang SX; Wu ZF; Zhang XW
    Yi Chuan; 2020 Jul; 42(7):641-656. PubMed ID: 32694104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclease-Mediated Gene Therapies for Inherited Metabolic Diseases of the Liver.
    Bryson TE; Anglin CM; Bridges PH; Cottle RN
    Yale J Biol Med; 2017 Dec; 90(4):553-566. PubMed ID: 29259521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver as a target for oligonucleotide therapeutics.
    Sehgal A; Vaishnaw A; Fitzgerald K
    J Hepatol; 2013 Dec; 59(6):1354-9. PubMed ID: 23770039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver targeted gene therapy: Insights into emerging therapies.
    Moscoso CG; Steer CJ
    Drug Discov Today Technol; 2019 Dec; 34():9-19. PubMed ID: 33357766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Highly Efficacious PS Gene Editing System Corrects Metabolic and Neurological Complications of Mucopolysaccharidosis Type I.
    Ou L; Przybilla MJ; Ahlat O; Kim S; Overn P; Jarnes J; O'Sullivan MG; Whitley CB
    Mol Ther; 2020 Jun; 28(6):1442-1454. PubMed ID: 32278382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From traditional pharmacological towards nucleic acid-based therapies for cardiovascular diseases.
    Landmesser U; Poller W; Tsimikas S; Most P; Paneni F; Lüscher TF
    Eur Heart J; 2020 Oct; 41(40):3884-3899. PubMed ID: 32350510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-viral Delivery of Zinc Finger Nuclease mRNA Enables Highly Efficient In Vivo Genome Editing of Multiple Therapeutic Gene Targets.
    Conway A; Mendel M; Kim K; McGovern K; Boyko A; Zhang L; Miller JC; DeKelver RC; Paschon DE; Mui BL; Lin PJC; Tam YK; Barbosa C; Redelmeier T; Holmes MC; Lee G
    Mol Ther; 2019 Apr; 27(4):866-877. PubMed ID: 30902585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene Editing With TALEN and CRISPR/Cas in Rice.
    Bi H; Yang B
    Prog Mol Biol Transl Sci; 2017; 149():81-98. PubMed ID: 28712502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designed nucleases for targeted genome editing.
    Lee J; Chung JH; Kim HM; Kim DW; Kim H
    Plant Biotechnol J; 2016 Feb; 14(2):448-62. PubMed ID: 26369767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for In Vivo Genome Editing in Nondividing Cells.
    Nami F; Basiri M; Satarian L; Curtiss C; Baharvand H; Verfaillie C
    Trends Biotechnol; 2018 Aug; 36(8):770-786. PubMed ID: 29685818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Cas9: A method for establishing rat models of drug metabolism and pharmacokinetics.
    Lu J; Liu J; Guo Y; Zhang Y; Xu Y; Wang X
    Acta Pharm Sin B; 2021 Oct; 11(10):2973-2982. PubMed ID: 34745851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-density lipoprotein receptor-deficient hepatocytes differentiated from induced pluripotent stem cells allow familial hypercholesterolemia modeling, CRISPR/Cas-mediated genetic correction, and productive hepatitis C virus infection.
    Caron J; Pène V; Tolosa L; Villaret M; Luce E; Fourrier A; Heslan JM; Saheb S; Bruckert E; Gómez-Lechón MJ; Nguyen TH; Rosenberg AR; Weber A; Dubart-Kupperschmitt A
    Stem Cell Res Ther; 2019 Jul; 10(1):221. PubMed ID: 31358055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vivo AAV-CRISPR/Cas9-Mediated Gene Editing Ameliorates Atherosclerosis in Familial Hypercholesterolemia.
    Zhao H; Li Y; He L; Pu W; Yu W; Li Y; Wu YT; Xu C; Wei Y; Ding Q; Song BL; Huang H; Zhou B
    Circulation; 2020 Jan; 141(1):67-79. PubMed ID: 31779484
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    VanLith CJ; Guthman RM; Nicolas CT; Allen KL; Liu Y; Chilton JA; Tritz ZP; Nyberg SL; Kaiser RA; Lillegard JB; Hickey RD
    Hepatol Commun; 2019 Apr; 3(4):558-573. PubMed ID: 30976745
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 28.